The majority (about 70–eighty%) of uveal melanoma addressed at the University Clinic Essen receive episcleral plaque therapy with no histological verification. This is why we didn't include a reference pathologist who reviews the diagnostic certainty with the scenarios. Activities from our previous case-Regulate reports confirmed that there's a a